checkAd

     141  0 Kommentare Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences - Seite 3

    Investor Contact:
    Michael Biega
    Senior Director, Investor Relations
    Sensei Biotherapeutics
    mbiega@senseibio.com

    Lesen Sie auch

    Media Contact:
    Joyce Allaire
    LifeSci Advisors
    Jallaire@lifesciadvisors.com 


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences - Seite 3 BOSTON, March 06, 2024 (GLOBE NEWSWIRE) - Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that the …